Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Quotes

Analysis

Analyst Ratings

News

Press Releases

Twitter

Media Mentions

Ownership

Earnings

ABIOMED, Inc. (ABMD) 23.00 0.07
Price Open:22.09Day's Range:0.00000 - 23.50000
Price Close:22.0052wk Range:0.00000 - 26.17
Price Day Change:0.07Volume:348,107
Price % Change:0.32Market Cap:829.4M
Bid:21.85000PE Ratio:59.46
Ask:23.00000EPS Diluted:0.37
Trade ABMD NOW!

The Latest On ABMD

Abiomed Receives Reimbursement Approval for Impella in The Netherlands 5/28/13 8:51am
Mid-Afternoon Market Update: Markets Remain Down, ABIOMED Rises 4/17/13 3:35pm
Mid-Day Market Update: Cirrus Logic Plunges On Weak Forecast, Atlas Energy Rises 4/17/13 12:51pm
Mid-Morning Market Update: Markets Move Lower, Bank of America Posts Downbeat Q1 Profit 4/17/13 10:17am
Benzinga's Top Pre-Market Gainers 4/17/13 8:48am
UPDATE: Piper Jaffray Downgrades ABIOMED to Neutral on PMA Pathway Risk 4/9/13 9:00am
Abiomed Reports Reimbursement Milestones: Says Four Commercial Insurers Start Broad Impella Coverage 3/4/13 9:16am
Tuesday February 26th Watchlist 2/26/13 9:43am
Mid-Day Market Update: Markets Largely Flat, Groupon Boosts 12/7/12 2:06pm
Abiomed Shares Lower as FDA Panel Votes to Retain Class III Status for Ventricular Support Devices 12/7/12 12:30pm
Abiomed Says Class Action Lawsuit Without Merit; Intends to Defend Vigorously 11/16/12 7:53pm
Abiomed Receives FDA IDE Approval for Use of New Impella RP in Pivotal Clinical Study 11/12/12 9:07am
more
Press Releases
Abiomed to Present at Goldman Sachs 34th Annual Global Healthcare Conference 6/6/13 GlobeNewswire
Abiomed to Present at William Blair 33rd Annual Growth Stock Conference 6/5/13 GlobeNewswire
Abiomed Receives Reimbursement Approval for Impella in The Netherlands 5/28/13 GlobeNewswire
Abiomed to Present at Deutsche Bank 38th Annual Health Care Conference 5/22/13 GlobeNewswire
Abiomed to Present at UBS Global Health Care Conference 5/17/13 GlobeNewswire
Abiomed to Present at Bank of America Merrill Lynch 2013 Health Care Conference 5/8/13 GlobeNewswire
Abiomed to Present at Bank of America Merrill Lynch 2013 Smid Cap Conference 5/3/13 GlobeNewswire
Abiomed Announces Fourth Quarter GAAP EPS of $0.09 on Record Revenue and Patients Supported 5/2/13 GlobeNewswire
Abiomed Announces Publication of Protect II Cost Effectiveness Study in American Health & Drug Benefits Journal 5/1/13 GlobeNewswire
Abiomed Announces Preliminary Fourth Quarter Revenue of $43.7 Million, Driven by Record Number of Patients Supported 4/17/13 GlobeNewswire
Abiomed Announces First Impella RP Patient Enrolled in Recover Right Study 4/1/13 GlobeNewswire
Abiomed's Impella(R) Technology Showcased at ACC 2013 3/7/13 GlobeNewswire

Get the latest ABMD stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for ABIOMED, Inc. stock price.

Partner Headlines
Abiomed Gains Reimbursement Approval - Analyst Blog 5/30/13
Abiomed Upped to Outperform - Analyst Blog 5/29/13
BSX and ABMD Highlight Increased Insider Buying in the Medical Technology Sector 5/14/13
HMA Matches Earnings, Misses Rev Est. - Analyst Blog 5/6/13
Thoratec Misses Earnings and Rev Est - Analyst Blog 5/6/13
Zacks #1 Rank Additions for Monday - Tale of the Tape 5/6/13
MWI Vet Earnings Beat, Sales Miss - Analyst Blog 5/3/13
Abiomed Earnings Beat in 4Q - Analyst Blog 5/3/13
Masimo Matches Earnings Est. - Analyst Blog 5/3/13
Dismal Earnings Miss by Omnicell - Analyst Blog 5/3/13
Merge 1Q13: Loss Widens; Meets Est - Analyst Blog 5/2/13
DexCom Loss Narrower than Est. - Analyst Blog 5/2/13